Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...

Within the past year, DSF has lectured on pneumococcal vaccination at two scientific ... 15.5 Non-VT: 6.1 Age: <5 years All types: 98.7 VT: 81.9 Non-VT: 6.8 Age: ≥65 years All types: 60.1 ...

Tdap is typically for people over age 7. A 2020 review reported ... respiratory complications. These vaccines include those for: COVID-19 the flu pneumococcal disease Tdap herpes zoster (shingles ...

At the moment, pneumococcal vaccination is recommended for the 65 and over age bracket in the US, although – following the Capvaxive approval – the CDC's Advisory Committee on Immunisation ...

Childhood vaccinations have not recovered from the slump that happened after the pandemic, according to new research.

“Vaccination against threats like pneumococcal disease aren't often top of mind at this age, but being proactive about your well-being is essential to making the most of this stage of life.

made up about half of cases in the 50-64 age group between 2018 and 2022. Capvaxive’s approval last summer made it the first pneumococcal vaccine designed specifically for adults aged 50 and old ...

STRIDE-6 (NCT05420961): A randomized descriptive Phase 3 study which evaluated CAPVAXIVE in individuals 50 years of age and older who had previously received a pneumococcal vaccine at least one ...

A lack of vaccination against respiratory pathogens was commonly identified among US international travelers, indicating the need to improve vaccine uptake at pre-travel visits.